Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome (PCOS) — High Yield

🩺 Polycystic Ovary Syndrome (PCOS)

Definition A common endocrine disorder in reproductive-age females characterized by hyperandrogenism, chronic anovulation, and polycystic ovaries. A major cause of reduced fertility.
Pathophysiology
  • Insulin Resistance: Hyperinsulinemia → altered hypothalamic feedback.
  • Hormonal Shift: ↑ LH:FSH ratio (relative).
  • Androgen Excess: ↑ Androgen production (testosterone) by theca interna cells.
  • Anovulation: ↓ Follicular maturation → unruptured follicles (cysts).
Clinical Features

Signs/Symptoms:

  • Hirsutism, acne, male-pattern baldness
  • Amenorrhea or Oligomenorrhea
  • Obesity & Acanthosis nigricans

Morphology:

Enlarged, bilateral cystic ovaries ("string of pearls" on US).

Long-term Risks

USMLE Key Point:

Increased risk of Endometrial Cancer due to unopposed estrogen from chronic anovulation. Also ↑ risk for Type 2 DM and Metabolic Syndrome.
Management
  • 1st Line: Weight reduction (improves insulin sensitivity).
  • Cycle Control: OCPs (prevent endometrial hyperplasia).
  • Fertility: Clomiphene or Letrozole (induces ovulation).
  • Hirsutism: Spironolactone (anti-androgen).

✨ High-Yield Pearls

  • 💎 Theca vs Granulosa: LH stimulates Theca cells (Androgens); FSH stimulates Granulosa cells (Estrogen). In PCOS, the balance shifts to Theca cells.
  • 💎 Metformin: Useful for metabolic control and can restore ovulation in some cases.
  • 💎 Diagnosis: Rotterdam criteria (2 out of 3: Anovulation, Hyperandrogenism, Polycystic ovaries on US).

Post a Comment

0 Comments